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I c  c a  a a  a   
 c c ac    COVID-19 a c   UK 
 
Ab ac  
Anal ing ne  na i n ide da a f m he Unde anding S cie  COVID-19 e  (N = 
10,336), hi  e ea ch e amine  in e ec ing e hnic and na i e mig an  ine ali ie  in he 
im ac  f COVID-19 n e le  ec n mic ell-being in he UK. The e l  h  ha  
c m a ed i h hi e na i e , black, A ian and min i  e hnic (BAME) mig an  in he UK 
a e m e likel   e e ience j b l  d ing he COVID-19 l ckd n, hile BAME na i e  
a e le  likel   enj  em l men  ec i n ch a  f l ghing. Al h gh hi e na i e  
a e m e likel   ed ce hei  k h  d ing he COVID-19 andemic han BAME 
mig an , he  a e le  likel   e e ience inc me l  and face inc ea ed financial ha d hi  
d ing he andemic han BAME mig an . The finding  h  ha  he andemic e ace ba e  
en enched ci -ec n mic ine ali ie  al ng in e ec ing e hnic and na i e mig an  line . 
The  ge g e nmen  and lic  make   lace acial j ice a  he cen e  f lic  
de el men  in e n e  he andemic.  
 
K : COVID-19, E hnici , Ec n mic Im ac , Ine ali , In e ec i nali , Mig an  
S a , UK 
 






Thi  e ea ch add e e   cial de el men  ha  ha e e  he ld in 2020. Fi , he 
COVID-19 andemic ha  had an n eceden ed im ac  n he gl bal ec n m  a  ell a  
indi id al  ec n mic ell-being (Ahmed e  al., 2020). Sec nd, he gl bal i e f aci m and 
an i- aci m m emen , f en ela ed  COVID-19 (C a e , 2020), ha  b gh   he f e 
l ng- anding, en enched e hnic ine ali ie  (Li & Hea h, 2016). E hnic di a i ie  in he 
heal h im ac  f COVID-19 a e ell d c men ed ac  man  c n ie  (Bhala e  al., 2020); 
m  n abl , COVID-19 infec i n and m ali  a e  a e m ch highe  am ng e le f m 
black, A ian and min i  e hnic (BAME) g  han hei  hi e c n e a . Ye  
in fficien  a en i n ha  been aid  e hnic ine ali ie ,  hei  in e ec i n  i h na i e
mig an  ine ali ie , in he ec n mic im ac  f COVID-19 (H e  e  al., 2020; La encin & 
McClin n, 2020). T  fill hi  ga , I anal e ne  na i n ide da a c llec ed b h bef e and 
af e  he andemic in he UK. I a k h , if a  all, he im ac  f COVID-19 n e le  
ec n mic ell-being diffe  i h hei  in e ec ing e hnic and mig an  a . I ake 
ad an age f he l ngi dinal de ign f he da a e   ca e he ec n mic im ac  f he 
andemic b  acing change  in e le  ec n mic ell-being bef e and d ing he 
andemic.  
  
2. DATA AND METHODS 
2.1.Da a a  a   
I anal ed da a f m he Unde anding S cie  (USOC) COVID-19 e  and eceding 
a e  f he e . Ini ia ed in 2009, USOC i  a na i nall  e e en a i e l ngi dinal anel 
e , hich ha  e am led BAME and mig an  g  (McFall, 2013). In A il 2020, 
he fi  a e f he USOC COVID-19 e  c llec ed da a f m 17,452 e nden  d ing 
he UK  na i nal l ckd n. While he eg la  USOC a e  c llec  da a f m face- -face 
in e ie , c m lemen ed b  mi ed-m de echni e , he COVID-19 e  a  
admini e ed h gh a elf-c m le ed e i nnai e n he in e ne . The ef e, a am ling 
eigh  a  ided b  he USOC eam  adj  f  en ial am le elec i n bia , hich 
a  ed in all f m  anal e .  
T  c n c  he anal ical am le, I fi  elimina ed e nden  h  did n  ha e a 
alid ec d in Wa e 9 f USOC, beca e I ed da a f m he eceding a e  b ain ke  
dem g a hic inf ma i n ha  a  n  c llec ed in he COVID-19 e . A  I anal ed 
change  in e le  em l men  a , I limi ed he am le  e nden  aged 20 65. La , 
I dele ed 1,377 ca e  i h mi ing inf ma i n n he a iable  ed in he anal i . The final 
anal ical am le c n ained 10,336 UK e iden  ( F ll Sam le ), f h m 8,281 e e ei he  
elf-em l ed  king a  an em l ee in Jan a Feb a  2020, bef e he COVID-19 
b eak in he UK ( W ke  Sam le ). See Online S lemen  f  de ailed inf ma i n n 
am le c n c i n. 
 
2.2.Ec c -b  ca  
T  ide ela i el  c m ehen i e c e age f he im ac  f COVID-19 n e le  
ec n mic ell-being, I f c ed n fi e indica . The de c i i e a i ic  a e e en ed in 
3 
 
A endi  1 and de ailed inf ma i n n mea emen  c n c i n can be f nd in he 
Online S lemen .  
Cha ge i  em l me  a . Ba ed n e le  em l men  and f l gh a  in 
Jan a Feb a  and A il 2020, I c ea ed a ca eg ical a iable  ca e change  and 
c n in i  in e le  em l men : n  change  (78%), l  j b  (4%), and f l ghed  
(18%). 
Cha ge i  ki g h . Ba ed n e le  king h  in Jan a Feb a  and 
A il 2020, I c ea ed a ca eg ical a iable  ca e change  and c n in i  in he 
e nden  king ime: inc ea ed  n  change  (53%), ( a ial) ed c i n in ime  
(16%), and al ime l  (31%). 
H eh ld i c me l . The e  a ked he e nden   e  he he  hei  
h eh ld had aken an  mea e   deal i h inc me l  d e  he andemic. I c ea ed a 
d mm  a iable  di ing i h he he  a e nden  k an  ac i n in e n e  h eh ld 
inc me l  ( e  = 41%).  
Diffic l  kee i g   da e i h bill . In Wa e 9 (2017 2019) and he COVID-19 
a e (A il 2020) f USOC, he e nden  e ed he he  he  e e   da e i h 
a i  bill . The e n e ca eg ie  e e   da e,  behind i h me bill ,  and 
behind i h all bill .  D e  cell i e c n ide a i n, I c mbined he la e   ca eg ie  
in  behind i h bill  (7%). I ed a d mm  a iable  ca e he he  e le had f nd 
i  m e diffic l   kee    da e i h hei  bill  d ing han bef e he andemic. 
Pe cei ed fi a cial ha d hi . In Wa e 9 and he COVID-19 a e f USOC, he 
e nden  e e a ked  de c ibe hei  financial i a i n, hich anged f m li ing 
c mf abl  h gh d ing al igh ,  j  ab  ge ing b  and finding i  i e diffic l  
 finding i  e  diffic l .  D e  cell i e c n ide a i n, I c mbined he la   
ca eg ie . I hen c ea ed a d mm  a iable  ca e he he  a e nden  f nd hei  
financial i a i n m e diffic l  d ing he andemic han bef e (21%).  
 
2.3.E c a  a  a  
Ba ed n he he  ne elf-iden ified a  a membe  f a BAME g  and he he  ne a  
b n in he UK, I di ing i hed he e nden  in e ec i nal e hnic mig an  a : hi e, 
na i e  (88%), hi e, mig an  (5%), BAME, na i e  (3%), and BAME, mig an  (4%). 
D e  mall am le i e  ( ee Online S lemen ), I a  n  able  f he  di ing i h 
ecific e hnic g .  
 
2.4.C  a ab  
I c n lled f  a e ie  f a iable : age (and i  ad a ic e m), gende , ed ca i n, m de f 
em l men  bef e he andemic ( elf-em l men , e  h  c n ac , e c.), h eh ld 
c m i i n, elf- e ed heal h, ban e idenc , l ng- e m h eh ld inc me, 
cc a i nal cla  (Na i nal S a i ic  S ci -ec n mic Cla ifica i n) and COVID-19 i k 
le el; he he  he e nden  e e ke  ke ; he he  he  c en l  ha e  had e e  
e ed COVID-19 m m   been e ed f  COVID-19; and he he  he  had ecei ed 
cial benefi  in Jan a Feb a  2020. Ma i al a  and egi n f e idence e e n  
incl ded, a  he  e e n  a i icall  ignifican l  a cia ed i h he c me a iable  
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and hei  incl i n nei he  affec ed he ke  edic  n  hel ed  im e he e all 
m del fi . 
 
2.5.A a ca  a  
I fi ed a e ie  f bina , de ed and m l in mial l gi  eg e i n m del  f  he di inc  
c me indica . Anal i  f he fi   c me indica  a  ba ed n he W ke  
Sam le and ha  f he he  c me indica  a  ba ed n he F ll Sam le. I e ima ed 
b  anda d e  cl e ed a  he h eh ld le el  acc n  f  in a-h eh ld 
c ela i n. I g a h edic i e ma gin   e en  he finding , and he f ll eg e i n e l  
a e e en ed in he Online S lemen .  
 
3. RESULTS  
3.1.E  a  c a  
Fig e 1 e en  he edic ed babili ie  f j b l  (Panel A) and f l gh (Panel B) 
d ing he COVID-19 l ckd n. The e l  h  he in e ec i nal di ad an age  faced b  
BAME mig an , h  e e 3.1 ime  m e likel   l e hei  j b  d ing he COVID-19 
l ckd n han hi e na i e  (10.1% . 3.3%, F [be een-g  diffe ence] = 9.09,  < 
0.01). C m a ed i h BAME na i e , hi e na i e  e e 1.7 ime  m e likel   be 
f l ghed (18.9% . 11.4%, F = 9.12,  < 0.01). While hi e na i e  e e 5.7 ime  m e 
likel   e e ience f l gh han j b l  (18.9% . 3.3%), he a e a  a  l  a  1.4 ime  
f  BAME mig an  (16.3% . 11.4%). The e e l , al ng i h he e l  I e  bel , 
a e af e  c n lling f  he fac  ha  BAME g  a e m e likel   be elf-em l ed and 
he elf-em l ed end  be m e ec n micall  ce ible  he COVID-19 l ckd n 
(Pla  & Wa ick, 2020).  
 
 
F . 1. P edic ed babili  f em l men  a  change  d ing he andemic 
N e : N = 8,281. E  ba  = 95% c nfidence in e al . 
 
3.2.W   c a  
Fig e 1 e en  he babili ie  f a a ial ed c i n in k h  (Panel A) and al 
k ime l  (Panel B) d ing he l ckd n f  h e h  e e in k in Jan a  and 
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Feb a  2020. C m a ed i h hi e na i e  (16.7%), BAME mig an  e e le  likel   
e e ience a ed c i n in hei  k h  d ing he l ckd n (10.7%, F = 6.36,  < 0.05). 
M e e , BAME na i e  a e le  likel   e e ience al k ime l  han hei  hi e 
na i e c n e a  (23.8% . 30.1%, F = 5.08,  < 0.05).  
 
 
F . 2. P edic ed babili  f k-h  change  d ing he andemic 
N e : N = 8,281. E  ba  = 95% c nfidence in e al .  
 
3.3.H  c   
Fig e 3 e en  he babili  f h eh ld inc me l  d ing he andemic. The e l  
h  ha  c m a ed i h hi e na i e  (39.6%), all BAME and mig an  g  e e m e 
likel   e e ience h eh ld inc me l  d ing he andemic, i h inc me l  being 1.3 
ime  (F = 16.48,  < 0.001), 1.2 ime  (F = 7.34,  < 0.01) and 1.2 ime  (F = 4.71,  < 0.05) 
m e likel  f  hi e mig an  (51.4%), BAME na i e  (49.3%) and BAME mig an  
(48.0%), e ec i el .   
 
  
F . 3. P edic ed babili  f h eh ld inc me l  d ing he andemic  






3.4.Fa  b   b  
Fig e 4 e en  he babili ie  f falling behind i h bill  (Panel A) and an inc ea e in he 
diffic l  f kee ing   da e i h bill  d ing he COVID-19 l ckd n (Panel B). The 
e l  in Panel A h  ha  BAME mig an  e e 2.2 ime  (14.4% . 6.5, F = 12.00,  < 
0.001) m e likel   e  being behind i h hei  bill  han hei  hi e na i e c n e a  
d ing he COVID-19 l ckd n. A imila  a e n a  b e ed f  an inc ea e in he 
diffic l  f kee ing   da e i h bill  d ing he l ckd n c m a ed i h bef e, a  
h n in Panel B. C m a ed i h hi e na i e  (4.6%), BAME mig an  (10.8%, F = 7.29,  
< 0.01) e e 2.3 ime  m e likel   e e ience an inc ea e in he le el f diffic l  f 
kee ing   da e i h hei  bill  d ing he andemic.  
 
 
F . 4. P edic ed babili  f being behind i h bill  d ing he andemic and g ea e  
diffic l  f a ing bill  d ing he andemic han bef e 
N e : N = 10,336. E  ba  = 95% c nfidence in e al . 
 
3.5.P c  a c a  a  
Fig e 5 e en  e le  elf- e ed financial i a i n (Panel  A D) and he babili  
f a ened financial i a i n d ing he andemic (Panel E). The e l  h  ha  
c m a ed i h hi e na i e , BAME mig an  e e le  likel   e  li ing c mf abl  
b  m e likel   e  e e iencing financial diffic l . S ecificall , hi e na i e  (28.8%) 
e e 1.4 ime  m e likel  han BAME mig an  (20.9%)  e  leading a financiall  
c mf able life d ing he andemic (F = 19.37,  < 0.001). In c n a , BAME mig an  
(11.1%) e e 1.5 ime  m e likel  han hi e na i e  (7.2%)  e  e e iencing financial 
diffic l  d ing he andemic (F = 12.34,  < 0.001). A  h n in Panel E, BAME mig an  
(26.6%) e e 1.3 ime  m e likel  han hi e na i e  (20.2%)  e e ience an inc ea e in 








F . 5. P edic ed babili  f elf- e ed financial i a i n d ing COVID-19 and 
ened financial i a i n d ing c m a ed i h bef e COVID-19  
N e : N = 10,336 e nden . E  ba  = 95% c nfidence in e al . 
 
4. CONCLUSIONS 
A  e en e  he hi d decade f he 21  cen , he COVID-19 andemic and he gl bal i e 
f aci m and an i- aci m m emen  a e  f he m  minen  de el men   define 
e le  li e  a nd he ld. The e  de el men  a e ine icabl  en angled (Bhala e  
al., 2020). In 2018, c m a ed i h hei  hi e c lleag e  d ing he ame k, BAME 
em l ee  ffe ed a age h fall f 3.2 billi n in he UK (T ham 2018). M  finding  
nc e  in e ec ing e hnic and na i e mig an  ine ali ie  in he im ac  f COVID-19 n 
e le  ec n mic ell-being, hich e ace ba e en enched ci -ec n mic di ad an age  
faced b  BAME mig an  in he UK (Li & Hea h, 2016, 2018). The e ine ali ie  a e e iden  
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in he nega i e im ac  f COVID-19 n e le  em l men  a , main enance f inc me, 
abili   kee    da e i h bill , and elf- e cei ed financial i a i n in he UK. Taken 
ge he , m  finding  nde line he im ance f c n ide ing cial g  li ing a  he 
in e ec i n f m l i le ma gin  f cie  (C llin  & Bilge, 2020), a  he andemic and 
a cia ed l ckd n ha e had a a ic la l  e e e im ac  n he ec n mic ell-being f 
BAME mig an  in he UK. M  finding  n  nl  ill a e he m ch m e e e e ec n mic 
ad e i  facing BAME mig an  han hi e na i e  d ing he andemic, b  al  indica e 
ha  BAME na i e  eem  enj  a l e  le el f em l men  ec i n, ch a  
f l ghing, han hei  hi e na i e c n e a .  
In f e e ea ch, i  ill be im an   ace he he  e hnic and na i e mig an  
ine ali ie  in he im ac  f COVID-19 n e le  ec n mic ell-being en a  he 
andemic de el . A  man  c n ie  a   ea e and lif  l ckd n mea e , i  ill al  
be c cial  e amine in e ec i nal ine ali ie  in e le  l ng- e m ajec  f (ec n mic) 
ec e . F he m e, hi  e ea ch ge  lic  make  and ac i i ne   de el  
ini ia i e  n  nl   ec  membe  f BAME and mig an  g  f m he ad e e 
ec n mic im ac  f he andemic, b  al   en e acial j ice a  ell a  b ade  cial 
j ice (K i al & Yai h, 2020; Qian & Wen, 2020) in he de ign and deli e  f cial 
ec i n and elfa e i i n d ing he e challenging ime . 
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A  1. Sam le cha ac e i ic  
 
All 
(N = 10,336) 
W ke  
(N = 8,281) 
 Mean/ i n   
E c  a  a  a 
    Whi e, na i e .88 .88 
    Whi e, mig an  .05 .05 
    BAME, na i e .03 .03 
    BAME, mig an  .04 .04 
Ec c -b     
Em l men - a  change    
    N    .78 
    J b l   .04 
    F l gh  .18 
W k-h  change  
    N  change  inc ea ed  .53 
    Pa ial ed c i n   .16 
    T al ime l   .31 
H eh ld inc me l  a .41 .43 
Behind i h bill  a .07 .06 
Inc ea ing diffic l  i h a ing bill   .05 .04 
Financial i a i n a 
    Li ing c mf abl  .28 .28 
    D ing al igh  .44 .46 
    J  ab  ge ing b  .20 .19 
    Q i e/ e  diffic l  .07 .07 
Inc ea e in financial ha d hi   .21 .20 
C  a ab  
Age a 45.17 44.19 
Age ( anda d de ia i n) (12.15) (11.53) 
Female a .54 .52 
Ed ca i n c 
    N   he  .17 .15 
    GCSE  .18 .18 
    A-le el .23 .22 
    Highe  deg ee .42 .45 
M de f em l men  b 
    Fi ed h  .54 .68 
    Fle ible h  .07 .09 
    Em l e  a igned h  (e.g., e  h  c n ac ) .07 .08 
    Self-em l ed .12 .15 
    N  em l ed .20  
Ke  ke  a .36 .44 
H eh ld c m i i n a 
    One ad l , n  child .09 .08 
    One ad l , a  lea  ne child .03 .03 
    M l i le ad l , n  child .49 .48 
    M l i le ad l , a  lea  ne child .38 .41 
COVID-19 a - i k la i n a   
    L   .78 .81 
    High  .18 .16 
    Ve  high  .04 .03 
COVID-19 e ed  m m  a .14 .15 
Self- e ed heal h c   
    E cellen  .12 .13 
    Ve  g d .37 .40 
    G d .33 .34 
    Fai  .13 .11 
    P   .05 .02 
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L ng- e m h eh ld inc me in ile c 
    1  (l e ) .21 .17 
    2nd  .21 .21 
    3 d  .20 .21 
    4 h  .19 .21 
    5 h (highe ) .19 .21 
Occ a i nal cla  (Na i nal S a i ic  S ci -ec n mic Cla ifica i n) c    
Semi- ine and ine .18 .21 
L e  e i  and echnical cc a i n .06 .07 
Small em l e  and n acc n  ke  .07 .08 
In e media e .11 .13 
Manage ial, admini a i e, and fe i nal .35 .41 
N  a licable ( nem l ed, inac i e, e c.) .23 .10 
Recei ed cial benefi  b .17 .11 
U ban e idenc  c .77 .77 
N e: BAME = black, A ian and min i  e hnic. GCSE = Gene al ce ifica e f ec nda  ed ca i n. Ke  
ke  = c i ical ke  ch a  medical aff. Weigh ed a i ic . See Online S lemen  f  de ailed 
mea emen  inf ma i n.  
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S a  Tab  S1. S e  f am le elec i n  
S e  Sam le elimina i n Remaining am le 
0  N = 17,452 (O a  a ) 
1 Dele e n  ma ching ec d in eceding Wa e 9 f 
Unde anding S cie   
N = 15,668 
2 Limi  age ange  20 65 (ac i e kf ce  a  he 
anal i  f c e  n e le  ec n mic and k a ; 
e i ed e le ecei ing [ a e] en i n a e nlikel   be 
affec ed b  he COVID-19 l ckd n in e m  f he 
c me indica  e amined in hi  e ea ch. The e l  
e ed in he a icle a e b   al e na i e am le  
im ing n  age limi a i n and a m e e ic i e age 
limi a i n f 25 54) 
N = 11,713 
3 Li i e dele i n f 1,377 e nden  i h mi ing 
inf ma i n f ll ing he de  bel :  
x 572: Em l men  a  d ing he COVID-19 
l ckd n 
x 7: F l gh d ing he COVID-19 l ckd n 
x 27: Em l men  a  bef e he COVID-19 
l ckd n 
x 120: L ng- e m inc me 
x 168: E hnici  / mig an  a  
x 12: M de f em l men  bef e he COVID-19 
l ckd n 
x 92: Ed ca i n 
x 1: COVID-19 i k la i n 
x 7: COVID-19 e ed  ha /had m m  
x 146: Self- e ed heal h 
x 6: Ke  ke  
x 7: U ban e idence 
x 77: Recei ed cial benefi  bef e he COVID-19 
l ckd n 
x 32: Inc me l  d ing he COVID-19 l ckd n 
x 53: Behind i h bill  d ing he COVID-19 
l ckd n 
x 27: G ea e  diffic l  a ing bill  d ing he COVID-
19 l ckd n han bef e 
x 15: Pe cei ed financial diffic l  d ing he COVID-
19 l ckd n 
x 8: G ea e  e cei ed financial diffic l  d ing he 
COVID-19 l ckd n 
A a ca  a  
N = 10,336 (F ll Sam le) 
N = 8,281 (W ke  Sam le: h e h  ked 
in Jan a  and Feb a  2020).  
N : F he  inf ma i n n he Unde anding S cie  COVID-19 e  i  a ailable f m 
h :// . nde anding cie .ac. k/ e ea ch/ heme /c id-19. Li le  mi ing c m le el  a  and m 





S a  Tab  S2. De ailed b eakd n f e hn - acial g  
 
F ll anal ical 
am le 
W king bef e 
COVID-19 
E hnic g  % %  
W  
Whi e B i i h 87.3 87.8 
Whi e I i h 1.0 1.0 
An  he  hi e backg nd 3.4 3.6 
BAME (b ac , A a  a   c)   
Mi ed ( hi e and black Ca ibbean) 0.5 0.5 
Mi ed ( hi e and black Af ican) 0.2 0.2 
Mi ed ( hi e and A ian) 0.3 0.3 
An  he  mi ed backg nd 0.3 0.4 
Indian 1.7 1.5 
Paki ani  1.1 0.9 
Banglade hi  0.4 0.4 
Chine e  0.4 0.4 
An  he  A ian backg nd  0.8 0.6 
Black Ca ibbean 0.8 0.7 
Black Af ican 1.1 1.0 
An  he  black backg nd 0.1 0.1 
A ab  0.2 0.2 
An  he  e hnic g  0.4 0.3 
N 10,336 8,281 
N : C l mn i n  ma  n  add   1 d e  nding. Weigh ed a i ic  i h n eigh ed am le 






S a  Tab  S3. Mea emen  e lana i n 
 Mea emen  e lana i n ( a iable name  in iginal da a e ) 
K  c   
E hnic  mig an  a  a Va iable gene a ed ba ed n  mea e : (1) he he  ne a  b n in he UK 
(b n k_d  & i_ kb n) and (2) elf- e ed e hnici  ( acel_d  & i_ acel_d ) 
Ec c -b    
Em l men  a  
change d ing he 
COVID-19 l ckd n a 
Va iable gene a ed ba ed n e le  elf- e ed k a  in Jan a -Feb a  
(ca_bl k) and A il 2020 (ca_ em de i ed), and he he  ne a  f l ghed in 
A il 2020 (ca_f l gh). 
The e  ec ded e le  em l men  a  in Jan a Feb a  and A il 2020, 
e ec i el , ing f  ca eg ie : em l ed,  elf-em l ed,  b h em l ed 
and elf-em l ed,  and n  em l ed.  The e  al  a ked he he  a e nden  
h  had been in k bef e he COVID-19 l ckd n a  f l ghed d ing he 
l ckd n. Ba ed n he e a iable  and he W ke  Sam le, I c ea ed a h ee-ca eg  
mea e  ca e change  and c n in i  in e le  em l men  a  bef e and 
d ing he COVID-19 l ckd n: (1) n  change , (2) l  j b , and (3) 
f l ghed .    
W k-h  change 
d ing he COVID-19 
l ckd n d 
Va iable gene a ed ba ed n e le  king h  in Jan a Feb a  
(ca_blh ) and A il 2020 (ca_h ), and elf- e ed change in king h  
bef e and d ing he COVID-19 l ckd n (ca_h change*).  
Re nden  f m he W ke  Sam le e e a ked  e  hei  eekl  king 
h  in Jan a Feb a  and A il 2020, e ec i el . Ba ed n he e mea e , I 
c ea ed a ca eg ical a iable  ca e change  and c n in i  in he e nden  
king h  bef e and d ing he COVID-19 l ckd n: (1) inc ea ed  n  
change , (2) a ial ed c i n in ime (  n n- e  h ) , and (3) al ime l  
(i.e., ed c i n  e  h ). 
 
H eh ld inc me l  
d ing he COVID-19 
l ckd n a 
Gene a ed ba ed n a ba e  f mea e  n e nden  (n n-) e n e  ea ning  
l  in A il 2020 (ca_in fl *). Im ed alid al e  f m a gi en h eh ld 
membe  f  he  h eh ld membe  i h mi ing al e  (< 1% f ca e ).  
The e  a ked he e nden   e  he he  hei  h eh ld had aken an  
mea e   deal i h h eh ld inc me l  d e  he COVID-19 andemic, ch a  
ed cing ending, ing a ing , b ing f m he bank, ing a c edi  ca d, a king 
f  hel  f m famil   f iend , finding ne  k,  inc ea ing hei  king h , 
 he he  an he  membe  f hei  h eh ld had f nd ne  k  inc ea ed hei  
king h . I hen c ea ed a d mm  a iable and c ded he e nden  a  ha ing 
e e ienced h eh ld inc me l  if he  e ed an  ac i n in e n e  
h eh ld inc me l . I did n  e elf- e ed inc me d ing COVID-19 d e  
highe  a e f mi ing al e  (32.9% f he COVID-19 e ). H e e , he e l  
ba ed n e le  elf- e ed inc me bef e and d ing he COVID-19 l ckd n 
and h  a m e e ic i e am le a e c n i en  i h h e ba ed n e le  elf-
e ed inc me l .  
Behind i h bill  d ing  
he COVID-19 l ckd n 
a 
Ba ed n a ingle mea e ca ing e nden  being behind i h bill  in A il 
2020 (ca_ bill _c ).  
In he c n ec i e Wa e 9 (2017 2019) and he fi  COVID-19 a e (A il 2020) f 
he e , he e nden  e e a ked  e  he he  he  e e   da e i h 
hei  bill  (i.e., h eh ld bill  ch a  elec ici , ga , a e , ele h ne, c ncil a , 
c edi  ca d  and he  bill ). Re n e  e e ec ded ing h ee ca eg ie :   
da e,  behind i h me bill ,  and behind i h all bill .  A  fe e  han 1% f he 
e nden  e ed ha  he  e e behind i h all bill ,  I c mbined he la e   
ca eg ie  in  ne ca eg : behind i h bill .  
G ea e  diffic l  i h 
a ing bill  d ing he 
COVID-19 l ckd n 
han bef e e 
Va iable gene a ed ba ed n he e i  mea e and a ingle mea e ca ing 
e nden  being behind i h bill  in Wa e 9 f Unde anding S cie  (i_ h dba). 
B  c m a ing he ame indi id al  e n e  f m Wa e 9 and he COVID-19 a e 
f he da a, I c ea ed a d mm  a iable  ca e he he  e le had f nd i  m e 
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diffic l   kee    da e i h hei  bill  d ing han bef e he COVID-19 andemic 
(i.e., a change in e n e be een he f me  and he la e  ca eg ie ). 
Pe cei ed financial 
i a i n d ing he 
COVID-19 l ckd n a 
Ba ed n a ingle mea e ca ing e nden  elf- e ed financial i a i n in 
A il 2020 (ca_finn ). 
In he c n ec i e Wa e 9 and COVID-19 a e f he e , he e nden  e e 
a ked  de c ibe hei  financial i a i n n a cale anging f m li ing c mf abl  
h gh d ing al igh ,  j  ab  ge ing b  and finding i  i e diffic l   
finding i  e  diffic l .  I c mbined he la   ca eg ie , d e  he mall 
i n (< 2%) f e nden  h  f nd hei  financial i a i n e  diffic l .  
 
G ea e  e cei ed 
financial ha d hi  d ing 
he COVID-19 l ckd n 
han bef e e 
Va iable gene a ed ba ed n he e i  mea e and a ingle mea e ca ing 
e nden  elf- e ed financial i a i n in Wa e 9 f Unde anding S cie  
(i_finn ). 
B  c m a ing he ame indi id al  e n e  f m Wa e 9 and he COVID-19 a e 
f he da a, I c ea ed a d mm  a iable  ca e he he  a e nden  f nd hei  
financial i a i n m e diffic l  d ing he COVID-19 l ckd n han bef e. 
C  a ab   
Age a Acc n ing f  age diffe ence ad a ic e m incl ded  acc n  f  en ial n n-
linea i . Age in A il 2020 (ca_age). 
Female ( ef. = male) a Acc n ing f  en ial gende  diffe ence. Self- e ed e  ( e _d ). 
Ed ca i n c Highe  le el f ed ca i n achie ed in Wa e 9 f Unde anding S cie  
(i_nhi al_d  & i_hi al_d ) 
M de f em l men  
bef e he COVID-19 
l ckd n b 
Gene a ed ba ed n  mea e : (1) elf- e ed em l men  a  in Jan a  and 
Feb a  2020 (ca_bl k) and (2) elf- e ed em al m de f em l men  in 
Jan a  and Feb a  2020 (ca_blh h ). 
x C n lled f  beca e e le in diffe en  m de  f em l men  (e.g., elf-
em l men , fi ed h  and e -h  c n ac ) ha e diffe en  le el  f 
lne abili   he COVID-19 andemic (l ckd n ).   
Ke  ke  ( ef. = n ) a Ke  ke  ma  be m e likel   be e ained f  k and e e ience an inc ea e in 
k ime d ing he andemic. A ingle mea e ca ing he he  ne elf-
iden ified a  a ke  ke  (i.e., c i ical ke  ch a  medical aff and eache  ha  
kee  e en ial cial e ice  f nc i nal d ing he COVID-19 l ckd n in he UK). 
F  f he  inf ma i n, ee: 
h :// .g . k/g e nmen / blica i n /c na i -c id-19-main aining-
ed ca i nal- i i n/g idance-f - ch l -c llege -and-l cal-a h i ie - n-
main aining-ed ca i nal- i i n  
x C n lled f  beca e he em l men  demand  and king ime diffe  
c n ide abl  be een ke  and n n-ke  ke  d ing he COVID-19 l ckd n.  
H eh ld c m i i n 
d ing he COVID-19 
l ckd n a 
Calc la ed ba ed n ne  elf- e ed n mbe  f child en age 0 4 (hhc m a), 5 15 
(hhc m b), 16 18 (hhc m c), ad l  age 19 69 (hhc m d) and 70 and e  
(hhc m e) in h eh ld, a a  f m ne elf.  
x C n lled f  beca e ci ec n mic c ndi i n  diffe  b  h eh ld 
c m i i n and h eh ld c m i i n end   a  ac  e hnic and na i e
mig an  g . 
COVID-19 a - i k 
la i n a 
COVID-19 i k la i n  ma  be m e likel   e e ience em l men  and h  
ec n mic change  d ing he andemic. A  e hnic min i ie  ha e been f nd  be 
m e likel   c n ac  and die f m COVID-19, i  i  im an   c n l f  COVID-
19 i k . Calc la ed ba ed n  e-de i ed a iable  c ea ed b  he Unde anding 
S cie  eam (ba ed n e nden  elf- e ed e-e i ing medical c ndi i n ): 
(1) he he  ne i  a  high i k f COVID-19 (ca_h i k_d ) and (2) he he  ne i  a  
e  high i k f COVID-19 (ca_ h i k_d ). F  f he  inf ma i n, ee: 
h :// . nde anding cie .ac. k/ i e /defa l /file /d nl ad /d c men a i n/c
id-19/ e -g ide /c id-19- e -g ide. df 
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x C n lled f  beca e a - i k la i n  ma  be m e likel   i hd a  f m 
ec n mic ac i i ie  and h  ec n mic ell-being d ing COVID-19.  
COVID-19 e ed  
ha e/had m m  a 
A  e hnic min i ie  ha e been f nd  be m e likel   c n ac  and die f m 
COVID-19, i  i  im an   c n l f  COVID-19 i k . C ea ed ba ed n h ee 
a iable : (1) he he  ne ha  been e ed f  COVID-19 (ca_ e ed), (2) he he  ne 
had COVID-19 m m  (ca_had m ), and (3) he he  ne ha  COVID-19 
m m  (ca_ha m ). The h ee mea e  a e c mbined in  ne d mm  mea e 
f  ea n : (1) he mall e cen age f e le i h a i i e e n e  each f he 
mea e ; (2) c nce all , e h ld e ec  COVID-19 m m  and e   affec  
e le  ec n mic ac i i ie  in a imila  manne , nde  he elf-i la i n lic .   
x COVID-19 m m  and e  a e likel   limi  e le  ec n mic ac i i  
a ici a i n and h  affec  e le  ec n mic ell-being.  
Self- e ed heal h 
bef e he COVID-19 
andemic c 
Self- e ed heal h in Wa e 9 f Unde anding S cie  (i_ c f1, a  he a iable i  
n  a ailable f m he COVID-19 e  a e).  
x Self- e cei ed heal h i  likel   be a cia ed i h e le  elf- e cei ed 
financial i a i n and diffic l ; and ( elf- e ed) heal h i  likel   infl ence 
e le  ca abili  f aid k a ici a i n.  
Q in ile f l ng- e m 
( h ee eceding a e  
f) h eh ld inc me  
Gene a ed ba ed n a e age h eh ld inc me da a f m eceding h ee a e  (i.e., 
Wa e  7 9) f Unde anding S cie  (g_fihhmng _d , h_fihhmng _d  & 
i_fihhmng _d ). F  a mall n mbe  f mi ing ca e , h eh ld inc me in Jan a  
and Feb a  2020 a  ed in ead (ca_blhhea n_an e ). Im ed alid al e  f m 
a gi en h eh ld membe  f  he  h eh ld membe  i h mi ing al e  (< 1% 
f ca e ). 
x Pe le f m diffe en  inc me g  ma  ha e diffe en  ba eline le el  f 
lne abili   he ec n mic im ac  f he COVID-19 andemic.  
Occ a i nal cla  Mea ed ing he 5-ca eg  Na i nal S a i ic  S ci -ec n mic Cla ifica i n f m 
Wa e 9 f he e  (i_jbn ec5_d ). Inf ma i n f m la  em l men  
(i_jln ec5_d ) im ed f  he nem l ed and inac i e. Re nden  i h n  
NSSEC inf ma i n a e c ded a  a e a a e ca eg . 
x Pe le f m diffe en  cc a i nal cla  g  ma  ha e diffe en  ba eline 
le el  f lne abili   he ec n mic im ac  f he COVID-19 andemic. 
Recei ed cial benefi  
bef e he COVID-19 
l ckd n ( ef. = n ) b 
Ba ed n fi e mea e  f he he  ne ecei ed Uni e al C edi  (ca_blbenefi 1), 
W king Ta  C edi  (ca_blbenefi 2), Child Ta  C edi  (ca_blbenefi 3), J b eeke  
All ance (ca_blbenefi 4), and Em l men  and S  All ance 
(ca_blbenefi 5) in Jan a  and Feb a  2020.  
x Pe le h  ha e / ha e n  ecei ed benefi  ma  ha e diffe en  ba eline le el  
f lne abili   he ec n mic im ac  f he COVID-19 andemic. 
U ban e idenc  ( ef. = 
al) c 
Ba ed n al ban e idence in Wa e 9 f Unde anding S cie  (i_ ban_d , a  
he a iable i  n  a ailable f m he COVID-19 e  a e). Im ed alid al e  
f m a gi en h eh ld membe  f  he  h eh ld membe  i h mi ing al e  
( nl  1 ca e). 
x Em l men  ni ie  and he di ib i n f e hnic and mig an  la i n 
diffe  be een al and ban a ea ; and he ec n mic c ndi i n  and ead f 
COVID-19 a e al  likel   diffe  be een al and ban a ea .  
N : GCSE = Gene al ce ifica e f ec nda  ed ca i n. Weigh ed a i ic  i h n eigh ed am le i e . 
F  ime-c n an  a iable  i h a mall n mbe  f mi ing al e  in he COVID-19 e  a e, alid al e 
f m eceding a e  f he e  e e ca ied f a d.  
a Da a c llec ed in A il 2020. b Da a c llec ed in A il 2020, efe ing e ec i el   Jan a Feb a  2020. 
c Da a c llec ed in 2017 2019 f m he eceding a e f he da a. d De i ed f m da a ce  (a) and (b). e





S a  Tab  S4. M l in mial l gi  eg e i n m del edic ing change  in em l men  
a  d ing he COVID-19 l ckd n (N = 8,281 ked bef e COVID-19, nde l ing m del 
f  Fig e 1) 
 M del 1 
 L ing j b ( . n  change) F l gh ( . n  change) 
P edic  B (SE) B (SE) 
E hnic  mig an  a  ( ef. = hi e, na i e)   
Whi e, mig an  0.140 0.161 
 (0.434) (0.201) 
BAME, na i e 0.288 0.698* 
 (0.384) (0.293) 
BAME, mig an  1.335*** 0.021 
 (0.324) (0.294) 
Age 0.189*** 0.052 
 (0.052) (0.031) 
Age2 0.002*** 0.001 
 (0.001) (0.000) 
Female ( ef. = male) 0.343 0.030 
 (0.177) (0.092) 
Ed ca i n ( ef. = n   he )   
GCSE 0.292 0.226 
 (0.333) (0.153) 
A-le el 0.281 0.177 
 (0.323) (0.147) 
Highe  deg ee 0.093 0.814*** 
 (0.307) (0.134) 
M de f king bef e he COVID-19 l ckd n ( ef. = 
fi ed h ) 
  
Fle ible h  0.256 0.054 
 (0.291) (0.141) 
Em l e  a igned h  0.851** 0.723*** 
 (0.308) (0.150) 
Self-em l ed 0.019 1.448*** 
 (0.253) (0.224) 
Ke  ke  ( ef. = n ) 18.317*** 2.641*** 
 (0.131) (0.131) 
H eh ld c m i i n d ing he COVID-19 l ckd n 
( ef. = ne ad l , n  child) 
  
One ad l , a  lea  ne child 0.130 0.479 
 (0.722) (0.300) 
M l i le ad l , n  child 0.126 0.009 
 (0.306) (0.176) 
M l i le ad l , a  lea  ne child 0.244 0.056 
 (0.378) (0.184) 
COVID-19 a - i k la i n ( ef. = l )   
High i k 0.075 0.162 
 (0.252) (0.128) 
Ve  high i k 0.316 0.095 
 (0.437) (0.241) 
COVID-19 e ed  ha e/had m m  ( ef. = n ) 0.209 0.022 
 (0.285) (0.129) 
Self- e ed heal h ( ef. = e cellen )   
Ve  g d 0.026 0.406** 
 (0.296) (0.152) 
G d 0.134 0.311* 
 (0.313) (0.158) 
Fai  0.269 0.439* 
 (0.410) (0.195) 
P  0.020 0.524 
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 (0.859) (0.358) 
L ng- e m h eh ld inc me in ile ( ef. = 1  [l e ])   
2nd 0.458 0.035 
 (0.294) (0.150) 
3 d  0.585* 0.083 
 (0.295) (0.148) 
4 h 0.456 0.469** 
 (0.295) (0.159) 
5 h (highe ) 0.781** 0.606*** 
 (0.278) (0.170) 
Occ a i n cla  ( ef. = Semi- ine and ine)   
L e  e i  and echnical cc a i n 0.401 0.339 
 (0.453) (0.190) 
Small em l e  and n acc n  ke  1.231** 1.680*** 
 (0.396) (0.287) 
In e media e 1.199*** 0.839*** 
 (0.341) (0.165) 
Manage ial, admini a i e, and fe i nal 1.095*** 1.066*** 
 (0.258) (0.138) 
N  a licable ( nem l ed, inac i e, e c.) 0.003 0.486** 
 (0.284) (0.168) 
Recei ed cial benefi  bef e he COVID-19 l ckd n 
( ef. = n ) 
0.708* 0.012 
(0.326) (0.164) 
U ban e idence ( ef. = al) 0.050 0.067 
 (0.212) (0.101) 
In e ce  1.905 1.557* 
 (1.092) (0.682) 
N : SE = S anda d e , hich a e cl e ed a  he h eh ld le el  acc n  f  i hin-h eh ld cl e ing. 
Ref. = Refe ence ca eg . A / b  c c : Va iance infla i n e  (VIF) h  ha  all VIF  a e 
bel  2.5, a a  f m h e f  age and age2. I al  fi ed al e na i e Fi h and e ac  l gi ic eg e i n m del , 
hich ielded c n i en  e l . The IIA a m i n a  a i fied f  he m l in mial ecifica i n. 







S a  Tab  S5. M l in mial l gi  eg e i n m del edic ing k-h  change  
d ing he COVID-19 l ckd n (N = 8,281 ked bef e COVID-19, nde l ing m del f  
Fig e 1) 
 M del 2 
 Red c i n in ime ( . n  
change  m e h ) 
T al ime l  ( . n  
change  m e h ) 
P edic  B (SE) B (SE) 
E hnic  mig an  a  ( ef. = hi e, na i e)   
Whi e, mig an  0.209 0.179 
 (0.194) (0.172) 
BAME, na i e 0.283 0.521* 
 (0.210) (0.211) 
BAME, mig an  0.508* 0.096 
 (0.258) (0.212) 
Age 0.003 0.110*** 
 (0.031) (0.026) 
Age2 0.000 0.001*** 
 (0.000) (0.000) 
Female ( ef. = male) 0.182* 0.384*** 
 (0.083) (0.079) 
Ed ca i n ( ef. = n   he )   
GCSE 0.314 0.196 
 (0.165) (0.135) 
A-le el 0.064 0.002 
 (0.153) (0.130) 
Highe  deg ee 0.057 0.569*** 
 (0.133) (0.120) 
M de f king bef e he COVID-19 l ckd n ( ef. = 
fi ed h ) 
  
Fle ible h  0.686*** 0.034 
 (0.130) (0.133) 
Em l e  a igned h  0.731*** 0.618*** 
 (0.157) (0.144) 
Self-em l ed 1.206*** 0.652*** 
 (0.139) (0.128) 
Ke  ke  ( ef. = n ) 0.167 2.194*** 
 (0.088) (0.094) 
H eh ld c m i i n d ing he COVID-19 l ckd n 
( ef. = ne ad l , n  child) 
  
One ad l , a  lea  ne child 0.449 0.761** 
 (0.288) (0.280) 
M l i le ad l , n  child 0.015 0.104 
 (0.164) (0.152) 
M l i le ad l , a  lea  ne child 0.273 0.381* 
 (0.177) (0.163) 
COVID-19 a - i k la i n ( ef. = l )   
High i k 0.184 0.022 
 (0.123) (0.111) 
Ve  high i k 0.078 1.032*** 
 (0.245) (0.202) 
COVID-19 e ed  ha e/had m m  ( ef. = n ) 0.025 0.141 
 (0.115) (0.105) 
Self- e ed heal h ( ef. = e cellen )   
Ve  g d 0.060 0.233 
 (0.129) (0.126) 
G d 0.086 0.305* 
 (0.133) (0.131) 
Fai  0.204 0.267 
 (0.180) (0.163) 
10 
 
P  0.184 0.153 
 (0.355) (0.320) 
L ng- e m h eh ld inc me in ile ( ef. = 1  [l e ])   
2nd  0.014 0.057 
 (0.154) (0.131) 
3 d  0.138 0.067 
 (0.157) (0.132) 
4 h  0.055 0.477*** 
 (0.154) (0.138) 
5 h (highe ) 0.014 0.544*** 
 (0.161) (0.145) 
Occ a i n cla  ( ef. = Semi- ine and ine)   
L e  e i  and echnical cc a i n 0.256 0.256 
 (0.210) (0.175) 
Small em l e  and n acc n  ke  0.588** 0.127 
 (0.215) (0.193) 
In e media e 0.328* 1.033*** 
 (0.165) (0.135) 
Manage ial, admini a i e, and fe i nal 0.079 1.110*** 
 (0.127) (0.117) 
N  a licable ( nem l ed, inac i e, e c.) 0.088 0.389** 
 (0.186) (0.145) 
Recei ed cial benefi  bef e he COVID-19 l ckd n 
( ef. = n ) 
0.039 0.193 
(0.150) (0.143) 
U ban e idenc  ( ef. = al) 0.005 0.022 
 (0.094) (0.088) 
In e ce  1.653* 2.503*** 
 (0.676) (0.580) 
N : SE = S anda d e , hich a e cl e ed a  he h eh ld le el  acc n  f  i hin-h eh ld 
cl e ing. Ref. = Refe ence ca eg . A / b  c c : Va iance infla i n e  (VIF) h  ha  
all VIF  a e bel  2.5, a a  f m h e f  age and age2. I al  fi ed al e na i e Fi h and e ac  l gi ic 
eg e i n m del , hich ielded c n i en  e l . The IAA a m i n a  a i fied f  he m l in mial 
ecifica i n.  




S a  Tab  S6. Reg e i n m del  f  Fig e  3 5 (N = 10,336 f  all m del ) 
 M del 3 M del 4 M del 5 M del 6 M del 7 
 F  Fig e 2: 
Bina  l gi  
m del edic ing 
inc me l  ( ef. 
= n ) 
F  Fig e 3 
(lef ): Bina  
l gi  m del 
edic ing being 
behind bill  ( ef. 
= n ) 
F  Fig e 3 
( igh ): Bina  
l gi  m del 
edic ing 
g ea e  diffic l  
a ing bill  han 
bef e ( ef. = 
n )  
F  Fig e 4 
( ): O de ed 
l gi  m del 
edic ing 
e cei ed 
financial 
diffic l  d ing 
COVID-19  
F  Fig e 4 
(b m): Bina  
l gi  m del 
edic ing 
g ea e  financial 
diffic l  han 
bef e ( ef. = 
n ) 
P edic  B (SE) B (SE) B (SE) B (SE) B (SE) 
E hnic  mig an  a       
( ef. = hi e, na i e)      
Whi e, mig an  0.573*** 0.556 0.576 0.294* 0.216 
 (0.140) (0.296) (0.305) (0.134) (0.175) 
BAME, na i e 0.476** 0.450* 0.208 0.232 0.049 
 (0.168) (0.220) (0.264) (0.134) (0.167) 
E hnic min i , mig an  0.414* 1.145*** 1.034*** 0.585*** 0.350* 
 (0.174) (0.251) (0.285) (0.144) (0.165) 
Age 0.015 0.046 0.026 0.075*** 0.006 
 (0.022) (0.048) (0.054) (0.020) (0.024) 
Age2 0.000 0.001 0.001 0.001*** 0.000 
 (0.000) (0.001) (0.001) (0.000) (0.000) 
Female ( ef. = male) 0.208*** 0.066 0.030 0.087 0.032 
 (0.060) (0.148) (0.160) (0.054) (0.068) 
Ed ca i n ( ef. = n   he )      
GCSE 0.023 0.265 0.105 0.025 0.109 
 (0.108) (0.212) (0.220) (0.089) (0.117) 
A-le el 0.049 0.060 0.166 0.030 0.079 
 (0.106) (0.221) (0.229) (0.089) (0.115) 
Highe  deg ee 0.004 0.192 0.379 0.280*** 0.112 
 (0.093) (0.199) (0.206) (0.079) (0.104) 
M de f king bef e he 
COVID-19 l ckd n ( ef. = 
fi ed h ) 
     
Fle ible h  0.225* 0.005 0.018 0.136 0.228 
 (0.110) (0.316) (0.339) (0.101) (0.127) 
Em l e  a igned h  0.359** 0.643** 0.571* 0.422*** 0.596*** 
 (0.130) (0.241) (0.278) (0.117) (0.136) 
Self-em l ed 1.304*** 1.035*** 1.132*** 0.855*** 0.787*** 
 (0.118) (0.231) (0.245) (0.115) (0.121) 
N  em l ed 0.192 0.706** 0.736* 0.476*** 0.556*** 
 (0.117) (0.259) (0.288) (0.106) (0.130) 
Ke  ke  ( ef. = n ) 0.397*** 0.052 0.178 0.090 0.177* 
 (0.073) (0.175) (0.200) (0.064) (0.086) 
H eh ld c m i i n d ing 
he COVID-19 l ckd n ( ef. = 
ne ad l , n  child) 
     
One ad l , a  lea  ne child 0.260 0.146 0.017 0.065 0.326 
(0.204) (0.349) (0.372) (0.195) (0.249) 
M l i le ad l , n  child 0.296* 0.496* 0.562* 0.133 0.100 
 (0.118) (0.235) (0.256) (0.098) (0.127) 
M l i le ad l , a  lea  ne 
child 
0.480*** 0.301 0.323 0.004 0.135 
(0.130) (0.235) (0.254) (0.108) (0.138) 
COVID-19 a - i k la i n 
( ef. = l ) 
     
High i k 0.104 0.203 0.086 0.156* 0.181* 
 (0.082) (0.182) (0.201) (0.070) (0.090) 
Ve  high i k 0.477** 0.080 0.340 0.036 0.130 
 (0.153) (0.273) (0.328) (0.134) (0.185) 
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COVID-19 e ed  ha e/had 
m m  
0.314*** 0.227 0.297 0.104 0.090 
(0.084) (0.176) (0.188) (0.080) (0.097) 
Self- e ed heal h ( ef. = 
e cellen ) 
     
     
Ve  g d 0.072 0.003 0.119 0.219* 0.057 
 (0.101) (0.272) (0.280) (0.093) (0.113) 
G d 0.177 0.274 0.190 0.426*** 0.108 
 (0.104) (0.275) (0.280) (0.097) (0.116) 
Fai  0.141 0.451 0.336 0.799*** 0.146 
 (0.128) (0.312) (0.330) (0.118) (0.141) 
P  0.345 0.718 0.555 0.925*** 0.088 
 (0.182) (0.376) (0.389) (0.168) (0.207) 
L ng- e m h eh ld inc me 
in ile ( ef. = 1  [l e ]) 
     
2nd  0.011 0.255 0.275 0.104 0.031 
 (0.106) (0.185) (0.209) (0.096) (0.116) 
3 d  0.128 0.327 0.290 0.141 0.109 
 (0.112) (0.205) (0.223) (0.100) (0.119) 
4 h  0.445*** 0.907*** 0.870** 0.341*** 0.040 
 (0.117) (0.258) (0.280) (0.103) (0.125) 
5 h (highe ) 0.528*** 0.943*** 0.896** 0.626*** 0.095 
 (0.119) (0.286) (0.299) (0.103) (0.127) 
Occ a i n cla  ( ef. = Semi-
ine and ine) 
     
L e  e i  and 
echnical cc a i n 
0.039 0.370 0.182 0.082 0.107 
(0.148) (0.341) (0.357) (0.141) (0.181) 
Small em l e  and n 
acc n  ke  
0.701*** 0.360 0.259 0.291 0.316 
(0.166) (0.279) (0.286) (0.157) (0.167) 
In e media e 0.204 0.483 0.639* 0.095 0.063 
(0.115) (0.263) (0.307) (0.100) (0.136) 
Manage ial, admini a i e, 
and fe i nal 
0.308** 0.449* 0.483* 0.250** 0.078 
(0.095) (0.202) (0.227) (0.082) (0.111) 
N  a licable ( nem l ed, 
inac i e, e c.) 
0.364** 0.429 0.482 0.483*** 0.395** 
(0.115) (0.231) (0.255) (0.104) (0.128) 
Recei ed cial benefi  bef e 
COVID-19 ( ef. = n ) 
0.157 1.076*** 0.992*** 0.501*** 0.196 
(0.106) (0.168) (0.185) (0.094) (0.116) 
U ban e idence ( ef. = al) 0.155* 0.302 0.305 0.174** 0.270** 
(0.073) (0.168) (0.182) (0.066) (0.082) 
Em l men  a  change 
d ing COVID-19 ( ef. = n ) 
     
L  j b 1.391*** 1.147** 1.283*** 0.722*** 0.442* 
 (0.217) (0.381) (0.357) (0.203) (0.193) 
F l gh 1.315*** 0.692*** 0.700** 0.563*** 0.471*** 
 (0.097) (0.207) (0.228) (0.087) (0.107) 
Behind bill  bef e he COVID-
19 l ckd n 
 2.084***    
 (0.181)    
Pe cei ed financial diffic l  
bef e he COVID-19 andemic 
( ef. = li ing c mf abl ) 
     
D ing al igh     1.546***  
    (0.078)  
J  (ab ) ge ing b     2.769***  
    (0.102)  
Finding i  i e/ e  diffic l     3.759***  
   (0.138)  
In e ce  0.979* 3.216** 2.638*  0.980 
 (0.480) (0.994) (1.134)  (0.518) 
C  1    1.686***  
    (0.443)  
C  2    4.457***  
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    (0.448)  
C  3    6.510***  
    (0.455)  
N : SE = S anda d e , hich a e cl e ed a  he h eh ld le el  acc n  f  i hin-h eh ld cl e ing. Ref. 
= Refe ence ca eg . A / b  c c : Va iance infla i n e  (VIF) h  ha  all VIF  a e bel  
2.5, a a  f m h e f  age and age2. P i nal a m i n f  de ed l gi  eg e i n i  a i fied. I al  fi ed 
al e na i e Fi h and e ac  l gi ic eg e i n m del , hich ielded c n i en  e l . 
*  < 0.05, **  < 0.01, ***  < 0.001 ( - ailed e ). 
 
 
